We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Customized PRK With Mitomycin Versus Customized Lasik for Myopic Astigmatism

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00365040
First Posted: August 17, 2006
Last Update Posted: August 17, 2006
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Federal University of São Paulo
  Purpose
The present study was designed to compare the use of mitomycin in PRK for the treatment of refractive errors and to compare these results to customized Lasik

Condition Intervention
Refractive Errors Procedure: Prk with mitomycin vs Lasik

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Treatment
Official Title: Customized PRK With Mitomycin Versus Customized Lasik for Myopic Astigmatism

Resource links provided by NLM:


Further study details as provided by Federal University of São Paulo:

Primary Outcome Measures:
  • visual acuity
  • refractive errors
  • topography patterns
  • aberrometry data

Secondary Outcome Measures:
  • subjective evaluation

Estimated Enrollment: 40
Study Start Date: December 2004
Estimated Study Completion Date: October 2006
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   21 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Myopia or compound myopic astigmatism, stable refractive error, no associated eye disease

Exclusion Criteria:

  • Diabetes, autoimmune diseases, topographic abnormalities
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00365040


Sponsors and Collaborators
Federal University of São Paulo
Investigators
Study Chair: Mauro Campos, MD Federal University of Sao Paulo
  More Information

ClinicalTrials.gov Identifier: NCT00365040     History of Changes
Other Study ID Numbers: AWMC
First Submitted: August 15, 2006
First Posted: August 17, 2006
Last Update Posted: August 17, 2006
Last Verified: July 2006

Keywords provided by Federal University of São Paulo:
myopia
excimer laser

Additional relevant MeSH terms:
Astigmatism
Refractive Errors
Eye Diseases
Mitomycins
Mitomycin
Antibiotics, Antineoplastic
Antineoplastic Agents
Alkylating Agents
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Enzyme Inhibitors